Chelsea Caya
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 detection and testing 4
- Viral gastroenteritis research and epidemiology 3
- Antimicrobial Resistance in Staphylococcus 3
- Clinical Biochemistry top 5%
- Epidemiology top 10%
- Respiratory viral infections research 9
- Pneumonia and Respiratory Infections 4
-
- Syphilis Diagnosis and Treatment 3
Chelsea Caya
23 papers receiving 595 citations
Peers
Comparison fields: 5 of 70
- Applied Microbiology and Biotechnology 31
- Infectious Diseases 274
- Clinical Biochemistry 94
- Epidemiology 322
- Critical Care and Intensive Care Medicine 28
Countries citing papers authored by Chelsea Caya
This map shows the geographic impact of Chelsea Caya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chelsea Caya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chelsea Caya more than expected).
Fields of papers citing papers by Chelsea Caya
This network shows the impact of papers produced by Chelsea Caya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chelsea Caya. The network helps show where Chelsea Caya may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chelsea Caya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 16 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 0 | |
| 11 | 2021 | 27 | |
| 12 | 2020 | 91 | |
| 13 | 2020 | 0 | |
| 14 | Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis | 2019 | 1 |
| 15 | 2018 | 29 | |
| 16 | 2018 | 3 | |
| 17 | 2017 | 11 | |
| 18 | 2017 | 13 | |
| 19 | 2016 | 16 | |
| 20 | 2015 | 11 |
About Chelsea Caya
Chelsea Caya is a scholar working on Infectious Diseases, Microbiology and General Social Sciences, having authored 26 papers that have together received 606 indexed citations. Recurring topics across this work include Respiratory viral infections research (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Pneumonia and Respiratory Infections (4 papers), COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 detection and testing (4 papers), Viral gastroenteritis research and epidemiology (3 papers), Syphilis Diagnosis and Treatment (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (31 citations), Infectious Diseases (274 citations) and Clinical Biochemistry (94 citations). Chelsea Caya has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Jesse Papenburg, Geneviève Gore, Nandini Dendukuri, Joanna Merckx, Caroline Chartrand, Ian Schiller, Cédric P. Yansouni, Matthew P. Cheng, Caroline Quach and Katryn Paquette.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.